Skip to content

Clinical trials

Completed Phase 3 Dyslipidemias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Status: Completed Clear all

137 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20026
20038
20046
200512
200623
200713
200810
20095
20113
20124
20136
20145
20153
20165
20172
20184
20192
20217
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed137

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda24
AstraZeneca13
Kowa Research Europe9
Abbott8
Amgen6
Amarin Pharma Inc.3
Boryung Pharmaceutical Co., Ltd3
Eisai Inc.3
JW Pharmaceutical3
NewAmsterdam Pharma3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias137
Hypercholesterolemia35
Diabetes Mellitus, Type 230
Diabetes Mellitus25
Glucose Metabolism Disorders22
Hypertension17
Hyperlipidemias16
Obesity12
Coronary Disease11
Cardiovascular Diseases10

Trials

Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.

37 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.